193. プラダー・ウィリ症候群 Prader-Willi syndrome Clinical trials / Disease details
臨床試験数 : 111 / 薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04685057 (ClinicalTrials.gov)  | January 11, 2021 | 2/12/2020 | Probiotic Treatment for Prader-Willi Syndrome | Probiotics as a Long-term Treatment Strategy for Prader-Willi Syndrome | Prader-Willi Syndrome | Dietary Supplement: Placebo;Dietary Supplement: Probiotic;Dietary Supplement: Follow-up probiotic | Fundació Sant Joan de Déu | NULL | Enrolling by invitation | 6 Years | 30 Years | All | 50 | Phase 1/Phase 2 | Spain | 
| 2 | NCT03548480 (ClinicalTrials.gov)  | January 1, 2018 | 2/5/2018 | Targeting the Gut Microbiome for Prader-Willi Syndrome Treatment | Targeting the Gut Microbiome for Prader-Willi Syndrome Treatment | Prader-Willi Syndrome | Dietary Supplement: Placebo;Dietary Supplement: Probiotic | Fundació Sant Joan de Déu | NULL | Completed | 2 Years | 19 Years | All | 39 | N/A | Spain |